AstraZeneca listing move would be ‘memorable loss’ to London market
AstraZeneca CEO Pascal Soriot, pictured in London on June 28, 2023, reportedly wants to move the company’s stock listing from London to the United States. Justin Tallis | Afp | Getty Images Pressure is piling on London’s stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet…